DexCom posts strong Q2 results, announces CEO change; Shares fall 4%

Published 30/07/2025, 21:28
 DexCom posts strong Q2 results, announces CEO change; Shares fall 4%

SAN DIEGO - DexCom , Inc. (NASDAQ:DXCM) reported second-quarter earnings and revenue that beat analyst expectations, but shares tumbled 4% as investors appeared unimpressed with the company’s performance despite raised guidance.

The continuous glucose monitoring (CGM) technology provider posted adjusted earnings of $0.48 per share for the second quarter, exceeding analyst estimates of $0.45. Revenue climbed 15% YoY to $1.16 billion, surpassing the consensus forecast of $1.12 billion.

DexCom’s U.S. revenue grew 15% to $841 million, while international revenue increased 16% to $316.1 million. The company’s sensor and other revenue, which represents 97% of total revenue, jumped 18% YoY to $1.12 billion, offsetting a 31% decline in hardware revenue.

"During the quarter, Dexcom delivered strong revenue results, presented compelling clinical data at ADA, and further advocated for expanded coverage in key growth markets," said Kevin Sayer, DexCom’s chairman and CEO.

Following the results, DexCom raised its full-year 2025 revenue guidance to $4.6-4.625 billion from its previous forecast, while maintaining its non-GAAP gross profit margin guidance of approximately 62% and operating margin of about 21%.

The company also announced a leadership transition, with Jake Leach set to become CEO effective January 1, 2026. Leach, who has been with DexCom for 21 years and currently serves as president and chief operating officer, will succeed Kevin Sayer, who will remain as executive chairman.

A significant milestone during the quarter was FDA clearance for the Dexcom G7 15 Day CGM System, which extends the wear time of the company’s continuous glucose monitoring sensors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.